Neurostimulation therapies for treatment resistant depression: A focus on vagus nerve stimulation and deep brain stimulation

References

• Bajbouj, M, Merkl, A, Schlaepfer, T.E., Frick, C, Zobel, A, Maier, W, …Heuser, I. (2010). Two-year outcome of vagus nerve stimulation in treatment-resistant depression. Journal of Clinical Psychopharmacology, 30, 273–281.
   PubMed Web of Science ®Google Scholar
• Benabid, A.L. (2007). What the future holds for deep brain stimulation. Expert Review of Medical Devices, 4, 895–903.
   PubMed Web of Science ®Google Scholar
• Bewernick, B.H., Hurlemann, R, Matusch, A, Kayser, S, Grubert, C, Hadrysiewicz, B, Schlaepfer, T.E. (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry, 67, 110–116.
   PubMed Web of Science ®Google Scholar
• Biggio, F, Gorini, G, Utzeri, C, Olla, P, Marrosu, F, Mocchetti, I. & Follesa, P. (2009). Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus. International Journal of Neuropsychopharmacology, 12, 1209–1221.
   PubMedGoogle Scholar
• Blood, A.J. & Zatorre, R.J. (2001). Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion. Proceedings of the National Academy of Science of the United States of America, 98, 11818–11823.
   PubMed Web of Science ®Google Scholar
• Bostwick, J.M. & Pankratz, V.S. (2000). Affective disorders and suicide risk: A reexamination. American Journal of Psychiatry, 157, 1925–1932.
   PubMed Web of Science ®Google Scholar
• Capuron, L, Raison, C.L., Musselman, D.L., Lawson, D.H., Nemeroff, C.B. & Miller, A.H. (2003). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. American Journal of Psychiatry, 160, 1342–1345.
   PubMedGoogle Scholar
• Carpenter, L.L., Moreno, F.A., Kling, M.A., Anderson, G.M., Regenold, W.T., Labiner, D.M. & Price, L.H. (2004). Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biological Psychiatry, 56, 418–426.
   PubMed Web of Science ®Google Scholar
• Carpenter, L.L., Bayat, L, Moreno, F, Kling, M.A., Price, L.H., Tyrka, A.R. & Nemeroff, C.B. (2008). Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy. Psychiatry Research, 157, 123–129.
   PubMed Web of Science ®Google Scholar
• Chae, J.H., Nahas, Z, Lomarev, M, Denslow, S, Lorberbaum, J.P., Bohning, D.E. & George, M.S. (2003). A review of functional neuroimaging studies of vagus nerve stimulation (VNS). Journal of Psychiatric Research, 37, 443–455.
   PubMed Web of Science ®Google Scholar
• Connor, T.J. & Leonard, B.E. (1998). Depression, stress and immunological activation: The role of cytokines in depressive disorders. Life Sciences, 62, 583–606.
   PubMed Web of Science ®Google Scholar
• Conway, C.R., Sheline, Y.I., Chibnall, J.T., George, M.S., Fletcher, J.W. & Mintun, M.A. (2006). Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Research, 146, 179–184.
   PubMed Web of Science ®Google Scholar
• Corcoran, C, Connor, T.J., O'Keane, V. & Garland, M.R. (2005). The effects of vagus nerve stimulation on pro-and anti-inflammatory cytokines in humans: A preliminary report. Neuroimmunomodulation, 12, 307–309.
   PubMedGoogle Scholar
• Cristancho, P, Cristancho, M.A., Baltuch, G.H., Thase, M.E. & O'Reardon, J.P. (2011). Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: Outcomes at 1 year. Journal of Clinical Psychiatry, 72, 1376–1382.
   PubMed Web of Science ®Google Scholar
• Cryan, J.F., Page, M.E. & Lucki, I. (2005). Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berlin), 182, 335–344.
   PubMed Web of Science ®Google Scholar
• Cunningham, J.T., Mifflin, S.W., Georgianna, G.G. & Frazer, A. (2008). Induction of c-Fos and ∆FosB immunoreactivity in rat brain by vagal nerve stimulation. Neuropsychopharmacology, 33, 1884–1895.
   PubMed Web of Science ®Google Scholar
• De Herdt, V, Bogaert, S, Bracke, K.R., Raedt, R, De Vos, M, Vonck, K, Boon, P. (2009). Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. Journal of Neuroimmunology, 214:104–108.
   PubMed Web of Science ®Google Scholar
• Dorr, A.E. & Debonnel, G. (2006). Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. Journal of Pharmacology & Experimental Therapeutics, 318, 890–898.
   PubMed Web of Science ®Google Scholar
• Epstein, J, Pan, H, Kocsis, J.H., Yang, Y, Butler, T, Chusid, J, … Silbersweig, D.A. (2006). Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. American Journal of Psychiatry, 2006;163:1784–1790.
   PubMed Web of Science ®Google Scholar
• Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry, 53, 649–659.
   PubMed Web of Science ®Google Scholar
• Geisler, S. & Trimble, M. (2008). The lateral habenula: No longer neglected. CNS Spectrums, 13, 484–489.
   PubMedGoogle Scholar
• George, M.S., Rush, A.J., Marangell, L.B., Sackeim, H.A., Brannan, S.K. … Goodnick, P. (2005). A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biological Psychiatry, 58, 364–373.
   PubMed Web of Science ®Google Scholar
• Gibson, T.B., Jing, Y, Smith Carls, G, Kim, E, Bagalman, J.E., Burton, W.N., … Goetzel, R.Z. (2010). Cost burden of treatment resistance in patients with depression. American Journal of Managed Care, 16, 370–377.
   PubMed Web of Science ®Google Scholar
• Greenberg, B.D., Malone, D.A., Friehs, G.M., Rezai, A.R., Kubu, C.S., Malloy, P.F., … Rasmussen, S.A. (2006). Three-year outcomes in deep brain stimulation for highly resistant obsessive–compulsive disorder. Neuropsychopharmacology, 31, 2384–2393.
   PubMed Web of Science ®Google Scholar
• Gutman, D.A., Holtzheimer, P.E., Behrens, T.E., Johansen-Berg, H. & Mayberg, H.S. (2009). A tractography analysis of two deep brain stimulation white matter targets for depression. Biological Psychiatry, 65, 276–282.
   PubMed Web of Science ®Google Scholar
• Guze, S.B. & Robins, E. (1970). Suicide and primary affective disorders. British Journal of Psychiatry, 117, 437–438.
   PubMed Web of Science ®Google Scholar
• Hamani, C, Mayberg, H, Snyder, B, Giacobbe, P, Kennedy, S. & Lozano, A.M. (2009). Deep brain stimulation of the subcallosal cingulate gyrus for depression: Anatomical location of active contacts in clinical responders and a suggested guideline for targeting. Journal of Neurosurgery, 111, 1209–1215.
   PubMed Web of Science ®Google Scholar
• Hamani, C, Diwan, M, Macedo, C.E., Brandão, M.L., Shumake, J, Gonzalez-Lima, F, Raymond, R, … Nobrega, J.N. (2010a). Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biological Psychiatry, 67, 117–124.
   PubMedGoogle Scholar
• Hamani, C, Diwan, M, Isabella, S, Lozano, A.M. & Nobrega, J.N. (2010b). Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats. Journal of Psychiatric Research, 44, 683–687.
   PubMedGoogle Scholar
• Hammad, T.A., Laughren, T.P. & Racoosin, J.A. (2006). Suicide rates in short-term randomized controlled trials of newer antidepressants. Journal of Clinical Psychopharmacology, 26, 203–207.
   PubMed Web of Science ®Google Scholar
• Handforth, A, DeGiorgio, C.M., Schachter, S.C., Uthman, B.M., Naritoku, D.K., Tecoma, E.S., … Whelas, J.W.(1998). Vagus nerve stimulation therapy for partial-onset seizures: A randomized active control trial. Neurology, 51, 48–55.
   PubMed Web of Science ®Google Scholar
• Hasler, G, Fromm, S, Carlson, P.J., Luckenbaugh, D.A., Waldeck, T, Geraci, M, … Drevets, W.C. (2008). Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of General Psychiatry, 65, 521–531.
   PubMed Web of Science ®Google Scholar
• Hernández, M.E., Mendieta, D, Martínez-Fong, D, Loría, F., Moreno, J, Estrada, I, …Pavón, L. (2008). Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. European Neuropsychopharmacology, 18, 917–924.
   PubMed Web of Science ®Google Scholar
• Ivanova, J.I., Birnbaum, H.G., Kidolezi, Y, Subramanian, G, Khan, S.A. & Stensland, M.D. (2010). Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder. Current Medical Research & Opinion, 26, 2475–2484.
   PubMed Web of Science ®Google Scholar
• Jiménez, F, Velasco, F, Salin-Pascual, R, Hernández, J.A., Velasco, M, Criales, J.L. & Nicolini, H. (2005). A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery, 57, 585–593.
   PubMed Web of Science ®Google Scholar
• Kennedy, S.H. & Giacobbe, P. (2007). Treatment resistant depression – Advances in somatic therapies. Annals of Clinical Psychiatry, 19, 279–287.
   PubMedGoogle Scholar
• Kennedy, S.H., Konarski, J.Z., Segal, Z.V., Lau, M.A., Bieling, P.J., McIntyre, R.S. & Mayberg, H.S. (2007). Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry, 164, 778–788.
   PubMed Web of Science ®Google Scholar
• Kennedy, S.H., Milev, R, Giacobbe, P, Ramasubbu, R, Lam, R.W., Parikh, S.V., … Canadian Network for Mood and Anxiety Treatments (CANMAT). (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. Journal of Affective Disorders, 117, S44–53.
   PubMedGoogle Scholar
• Kennedy, S.H., Giacobbe, P, Rizvi, S.J., Placenza, F.M., Nishikawa, Y, Mayberg, H.S. & Lozano, A.M. (2011). Deep brain stimulation for treatment-resistant depression: Follow-up after 3 to 6 years. American Journal of Psychiatry, 168, 502–510.
   PubMed Web of Science ®Google Scholar
• Kosel, M, Brockmann, H, Frick, C, Zobel, A. & Schlaepfer, T.E. (2011). Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Research, 191, 153–159.
   PubMed Web of Science ®Google Scholar
• Konarski, J.Z., Kennedy, S.H., Segal, Z.V., Lau, M.A., Bieling, P.J., McIntyre, R.S. & Mayberg, H.S. (2009). Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of Psychiatry and Neuroscience, 34, 175–180.
   PubMed Web of Science ®Google Scholar
• Krahl, S.E., Senanayake, S.S., Pekary, A.E. & Sattin, A. (2004). Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. Journal of Psychiatric Research, 38, 237–240.
   PubMedGoogle Scholar
• Li, M, Soczynska, J.K. & Kennedy, S.H. (2011a). Inflammatory biomarkers in depression: An opportunity for novel therapeutic interventions. Current Psychiatry Reports, 13, 316–320.
   PubMedGoogle Scholar
• Li, B, Piriz, J, Mirrione, M, Chung, C, Proulx, C.D., Schulz, D, … Malinow, R. (2011b). Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature, 470, 535–539.
   PubMed Web of Science ®Google Scholar
• Lipsman, N, McIntyre, R.S., Giacobbe, P, Torres, C, Kennedy, S.H. & Lozano, A.M. (2010). Neurosurgical treatment of bipolar depression: Defining treatment resistance and identifying surgical targets. Bipolar Disorders, 12, 691–701.
   PubMed Web of Science ®Google Scholar
• Lozano, A.M., Dostrovsky, J, Chen, R. & Ashby, P. (2002). Deep brain stimulation for Parkinson's disease: Disrupting the disruption. Lancet Neurology, 1, 225–231.
   PubMed Web of Science ®Google Scholar
• Lozano, A.M., Mayberg, H.S., Giacobbe, P, Hamani, C, Craddock, R.C. & Kennedy, S.H. (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry, 64, 461–467.
   PubMed Web of Science ®Google Scholar
• Lozano, A.M., Giacobbe, P, Hamani, C, Rizvi, S, Kennedy, S.H., Kolivakis, T.T., … Mayberg, HS. (2011). A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment resistant depression. Journal of Neurosurgery, DOI: 10.3171/2011.10.JNS102122.
   Google Scholar
• Majoie, H.J., Rijkers, K, Berfelo, M.W., Hulsman, J.A., Myint, A, Schwarz, M. & Vles, J.S. (2011). Vagus nerve stimulation in refractory epilepsy: Effects on pro- and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation, 18, 52–56.
   PubMed Web of Science ®Google Scholar
• Malhi, G.S. & Berk, M. (2007). Does dopamine dysfunction drive depression? Acta Psychiatrica Scandinavica Supplementum, 433, 116–124.
   Google Scholar
• Malone, D.A. Jr, Dougherty, D.D., Rezai, A.R., Carpenter, L.L., Friehs, G.M., Eskandar, E.N., … Greenberg, B.D. (2009). Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biological Psychiatry, 65, 267–275.
   PubMed Web of Science ®Google Scholar
• Manta, S, Dong, J, Debonnel, G. & Blier, P. (2009a). Enhancement of function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. Journal of Psychiatry & Neuroscience, 24, 272–280.
   Google Scholar
• Manta, S, Dong, J, Debonnel, G. & Blier, P. (2009b). Optimization of vagus nerve stimulation parameters using the firing activity of serotonin neurons in the rat dorsal raphe. European Neuropsychopharmacology, 19, 250–255.
   PubMedGoogle Scholar
• Marangell, L.B., Rush, A.J., George, M.S., Sackeim, H.A., Johnson, C.R., Husain, M.M., … Lisanby, S.H. (2002). Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes. Biological Psychiatry, 51, 280–287.
   PubMed Web of Science ®Google Scholar
• Marangell, L.B., Suppes, T, Zboyan, H.A., Prashad, S.J., Fischer, G, Snow, D, … Allen, J.C. (2008). A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. Journal of Clinical Psychiatry, 69, 183–189.
   PubMedGoogle Scholar
• Matsumoto, M. & Hikosaka, O. (2007). Lateral habenula as a source of negative reward signals in dopamine neurons. Nature, 447, 1111–1115.
   PubMed Web of Science ®Google Scholar
• Mayberg, H.S., Liotti, M, Brannan, S.K., McGinnis, S, Mahurin, R.K., … Fox, PT. (1999). Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. American Journal of Psychiatry, 156, 675–682.
   PubMed Web of Science ®Google Scholar
• Mayberg, H.S., Lozano, A.M., Voon, V, McNeely, H.E., Seminowicz, D, Hamani, C, … Kennedy, S.H. (2005). Deep brain stimulation for treatment-resistant depression. Neuron, 45, 651–660.
   PubMed Web of Science ®Google Scholar
• McCracken, C.B. & Grace, A.A. (2007). High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. Journal of Neuroscience, 27, 12601–12610.
   PubMedGoogle Scholar
• McCracken, C.B. & Grace, A.A. (2009). Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo. Journal of Neuroscience, 29, 5354–5363.
   PubMedGoogle Scholar
• Miller, A.H., Maletic, V. & Raison, C.L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732–741.
   PubMed Web of Science ®Google Scholar
• Morris, J.S., Smith, K.A., Cowen, P.J., Friston, K.J. & Dolan, R.J. (1999). Covariation of activity in habenula and dorsal raphé nuclei following tryptophan depletion. Neuroimage, 10, 163–172.
   PubMed Web of Science ®Google Scholar
• Mussap, C.J., Geraghty, D.P. & Burcher, E. (1993). Tachykinin receptors: A radioligand binding perspective. Journal of Neurochemistry, 60, 1987–2009.
   PubMed Web of Science ®Google Scholar
• Nahas, Z, Marangell, L.B., Husain, M.M., Rush, A.J., Sackeim, H.A., Lisanby, S.H., … George, MS. (2005). Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. Journal of Clinical Psychiatry, 66, 1097–1104.
   PubMed Web of Science ®Google Scholar
• Nemeroff, C.B., Mayberg, H.S., Krahl, S.E., McNamara, J, Frazer, A, Henry, T.R., …Brannan, S.K. (2006). VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology, 31, 1345–1355.
   PubMed Web of Science ®Google Scholar
• Nierenberg, A.A., Alpert, J.E., Gardner-Schuster, E.E., Seay, S. & Mischoulon, D. (2008). Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biological Psychiatry, 64, 455–460.
   PubMed Web of Science ®Google Scholar
• Nowak, L.G. & Bullier, J. (1998). Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments. Expert Brain Research, 118, 489–500.
   PubMed Web of Science ®Google Scholar
• Nuttin, B, Cosyns, P, Demeulemeester, H, Gybels, J. & Meyerson, B. (1999). Electrical stimulation in anterior limbs of internal capsules in patients with obsessive–compulsive disorder. Lancet, 354, 1526.
   PubMed Web of Science ®Google Scholar
• O'Brien, S.M., Scully, P, Fitzgerald, P, Scott, L.V. & Dinan, T.G. (2007). Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. Journal of Psychiatric Research, 41, 326–331.
   PubMed Web of Science ®Google Scholar
• Pardo, J.V., Sheikh, S.A., Schwindt, G.C., Lee, J.T., Kuskowski, M.A., Surerus, C, … Rittberg, B.R. (2008). Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. Neuroimage, 42, 879–889.
   PubMedGoogle Scholar
• Pizzagalli, D.A., Iosifescu, D, Hallett, L.A., Ratner, K.G. & Fava, M. (2008). Reduced hedonic capacity in major depressive disorder: Evidence from a probabilistic reward task. Journal of Psychiatric Research, 43, 76–87.
   PubMed Web of Science ®Google Scholar
• Puigdemont, D, Pérez-Egea, R, Portella, M.J., Molet, J, de Diego-Adeliño, J., Gironell, A, …Pérez, V. (2011). Deep brain stimulation of the subcallosal cingulate gyrus: Further evidence in treatment-resistant major depression. International Journal of Neuropsychopharmacology, 2011, 22:1–13.
   Google Scholar
• Ranft, K, Dobrowolny, H, Krell, D, Bielau, H, Bogerts, B. & Bernstein, H.G. (2010). Evidence for structural abnormalities of the human habenular complex in affective disorders but not in schizophrenia. Psychological Medicine, 40, 557–567.
   PubMedGoogle Scholar
• Rauch, S.L. (2003). Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders. Neurosurgery Clinics of North America, 14, 213–223.
   PubMed Web of Science ®Google Scholar
• Rawlins, P. (1997). Are there benefits, in addition to improved seizure control, for children receiving vagus nerve stimulation? Epilepsia, 38S8, S155–156.
   Google Scholar
• Ressler, K.J. & Mayberg, H.S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic. Nature Neuroscience, 10, 1116–1124.
   PubMed Web of Science ®Google Scholar
• Revesz, D, Tjernstrom, M, Ben-Menachem, E. & Thorlin, T. (2008). Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Expert Neurology, 214, 259–265.
   PubMed Web of Science ®Google Scholar
• Rizvi, S.J., Kennedy, S.H., Giacobbe, P, Mayberg, H.S. & Lozano, A.M. (2011). Subcallosal cingualte gyrus deep brain stimulation for refractory major depressive disorder: Difference in FDG-PET between responders and non-responders. Biological Psychiatry, 69S9, S173.
   Google Scholar
• Rush, A.J., George, M.S., Sackeim, H.A., Marangell, L.B., Husain, M.M., Giller, C, … Goodman, R. (2000). Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study. Biological Psychiatry, 47, 276–286.
   PubMed Web of Science ®Google Scholar
• Rush, A.J., Marangell, L.B., Sackeim, H.A., George, M.S., Brannan, S.K., Davis, S.M., … Cooke, R.G. (2005). Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biological Psychiatry, 58, 347–354.
   PubMed Web of Science ®Google Scholar
• Sackeim, H.A., Rush, A.J., George, M.S., Marangell, L.B., Husain, M.M., Nahas, Z, … Goodman, R.R. (2001a). Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology, 25, 713–728.
   PubMed Web of Science ®Google Scholar
• Sackeim, H.A., Keilp, J.G., Rush, A.J., George, M.S., Marangell, L.B., Dormer, J.S., … Zboyan, H. (2001b). The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14, 53–62.
   PubMedGoogle Scholar
• Sartorius, A, Kiening, K.L., Kirsch, P, von Gall, C.C., Haberkorn, U, Unterberg, A.W., … Meyer-Lindenberg, A. (2010). Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biological Psychiatry, 67, e9–e11.
   PubMed Web of Science ®Google Scholar
• Schlaepfer, T.E., Frick, C, Zobel, A, Maier, W, Heuser, I, Bajbouj, M, O'Keane, V, … Hasdemir, M. (2008a). Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychological Medicine, 38, 651–661.
   PubMed Web of Science ®Google Scholar
• Schlaepfer, T.E., Cohen, M.X., Frick, C, Kosel, M, Brodesser, D, Axmacher, N, … Sturm, V. (2008b). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology, 33, 368–377.
   PubMed Web of Science ®Google Scholar
• Senior, C. (2003). Beauty in the brain of the beholder. Neuron, 38, 525–528.
   PubMed Web of Science ®Google Scholar
• Shen, H, Fuchino, Y, Miyamoto, D, Nomura, H. & Matsuki, N. (2011).Vagus nerve stimulation enhances perforant path-CA3 synaptic transmission via the activation of β-adrenergic receptors and the locus coeruleus. International Journal of Neuropsychopharmacology, DOI: 10.1017/S1461145711000708
   Google Scholar
• Shuchman, M. (2007). Approving the vagus-nerve stimulator for depression. New England Journal of Medicine, 356, 1604–1607.
   PubMedGoogle Scholar
• Shumake, J. & Gonzalez-Lima, F. (2003). Brain systems underlying susceptibility to helplessness and depression. Behavior and Cognition Neuroscience Review, 2, 198–221.
   PubMedGoogle Scholar
• Souery, D, Amsterdam, J, de Montigny, C, Lecrubier, Y, Montgomery, S, Lipp, O, … Mendlewicz, J. (1999). Treatment resistant depression: methodological overview and operational criteria. European Neuropsychopharmacology, 9, 83–91.
   PubMed Web of Science ®Google Scholar
• Thase, M.E. & Rush, A.J. (1997). When at first you don't succeed: Sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry, 58S13, S23–29.
   Google Scholar
• Velasco, F, Velasco, M, Jiménez, F, Velasco, A.L. & Salin-Pascual, R. (2005). Neurobiological background for performing surgical intervention in the inferior thalamic peduncle for treatment of major depression disorders. Neurosurgery, 57, 439–448.
   PubMed Web of Science ®Google Scholar
• Velasco, M, Velasco, F, Jiménez, F, Carrillo-Ruiz, J.D., Velasco, A.L. & Salín-Pascual, R. (2006). Electrocortical and behavioral responses elicited by acute electrical stimulation of inferior thalamic peduncle and nucleus reticularis thalami in a patient with major depression disorder. Clinical Neurophysiology, 117, 320–327.
   PubMed Web of Science ®Google Scholar
• Vitek, J.L. Mechanisms of deep brain stimulation: Excitation or inhibition. Movement Disorders, 17S3, S69–72.
   Google Scholar
• Warden, D, Rush, A.J., Trivedi, M.H., Fava, M. & Wisniewski, S.R. (2007). The STAR*D Project results: A comprehensive review of findings. Currrent Psychiatry Reports, 9, 449–459.
   PubMedGoogle Scholar
• Zobel, A, Joe, A, Freymann, N, Clusmann, H, Schramm, J, Reinhardt, M, … Broich, K. (2005). Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach. Psychiatry Research, 139, 165–179.
   PubMed Web of Science ®Google Scholar